Adrienne Phillips, MD, MPH, hematologist/oncologist, Director of Cell Therapy and Bone Marrow Transplantation Northern Regions, RWJBarnabas Health, associate professor, medicine, Rutgers Robert Wood Johnson Medical School, discusses the impact of CAR T-cell therapy on the treatment paradigm for patients with large B-cell lymphoma, highlighting key advancements in the decision-making process for CAR T-cell therapy selection. Watch more at onclive.com.